UAE
New Pill for Vitiligo Debuts in Dubai as Nation Speeds Up Drug Approvals

The UAE has approved a new oral treatment for vitiligo, making it the first country in the world to authorize the therapy.
The UAE has become the first country globally to approve and launch a new oral treatment for vitiligo, an announcement made on Friday, 6 November, at the 10th Emirates Dermatology Conference in Dubai. The three-day event at InterContinental Dubai – Festival City has convened over 500 international physicians to discuss breakthroughs in clinical imaging and pharmaceutical innovation. Global First for Vitiligo Care Dr. Ayman Alnaeem, President of the Emirates Dermatology Society and President of the Conference, confirmed the landmark regulatory approval during his opening address. The launch of the oral therapy, the specific name of which was not disclosed in the initial announcement, positions the UAE ahead of other global regulators in adopting the treatment. Alongside the vitiligo medication, the conference will debut a new generation of biological treatments for psoriasis and other inflammatory skin conditions. The announcement underscores the UAE’s strategy of expedited medicine registration. According to Dr. Alnaeem, the country ranks among the fastest globally in approving new pharmaceuticals and is a lead adopter of artificial intelligence for diagnosing skin cancer and…
Source: WAM (Emirates News Agency)